PE20060624A1 - Derivados de acido acetico con sustituyentes ciclohexilmetoxi como moduladores de los receptores ppar - Google Patents
Derivados de acido acetico con sustituyentes ciclohexilmetoxi como moduladores de los receptores pparInfo
- Publication number
- PE20060624A1 PE20060624A1 PE2005000924A PE2005000924A PE20060624A1 PE 20060624 A1 PE20060624 A1 PE 20060624A1 PE 2005000924 A PE2005000924 A PE 2005000924A PE 2005000924 A PE2005000924 A PE 2005000924A PE 20060624 A1 PE20060624 A1 PE 20060624A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- acetic acid
- cyclohexylmetoxi
- modulators
- substitutes
- Prior art date
Links
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 title 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 title 1
- 150000001242 acetic acid derivatives Chemical class 0.000 title 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 3
- 239000003614 peroxisome proliferator Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229940126601 medicinal product Drugs 0.000 abstract 2
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical class [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
REFERIDA A UN COMPUESTO DERIVADO DE ACIDO ACETICO DE FORMULA I, DONDE R1 ES H, ALQUILO C1-C6; R2 ES H, CF3 O ALQUILO C1-C3; R3 ES ALQUILO C1-C6; R4 ES ALQUILO C1-C6, BENCILO; R5 ES H O ALQUILO C1-C6. TAMBIEN ESTA REFERIDA A UN MEDICAMENTO Y A UN PROCEDIMIENTO DE PREPARACION DE ESTE MEDICAMENTO. DICHO COMPUESTO ES MODULADOR DE LOS RECEPTORES ACTIVADOS POR EL PROLIFERADOR DE PEROXISOMAS (PPAR), PARTICULARMENTE PPAR GAMMA Y ES UTIL PARA EL TRATAMIENTO DE TRASTORNOS DEL METABOLISMO DE LOS ACIDOS GRASOS Y DE LA GLUCOSA, ENTRE OTROS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004039532A DE102004039532B4 (de) | 2004-08-14 | 2004-08-14 | Cyclohexyl-methyloxy substituierte Essigsäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20060624A1 true PE20060624A1 (es) | 2006-07-27 |
Family
ID=35159900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005000924A PE20060624A1 (es) | 2004-08-14 | 2005-08-10 | Derivados de acido acetico con sustituyentes ciclohexilmetoxi como moduladores de los receptores ppar |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7956077B2 (es) |
| EP (1) | EP1778655B1 (es) |
| JP (1) | JP2008509891A (es) |
| KR (1) | KR20070040813A (es) |
| CN (1) | CN101031553A (es) |
| AR (1) | AR050290A1 (es) |
| AT (1) | ATE430739T1 (es) |
| AU (1) | AU2005274492A1 (es) |
| BR (1) | BRPI0513999A (es) |
| CA (1) | CA2576545A1 (es) |
| DE (2) | DE102004039532B4 (es) |
| DK (1) | DK1778655T3 (es) |
| ES (1) | ES2326423T3 (es) |
| IL (1) | IL181010A0 (es) |
| MX (1) | MX2007000913A (es) |
| PE (1) | PE20060624A1 (es) |
| PT (1) | PT1778655E (es) |
| SV (1) | SV2006002191A (es) |
| TW (1) | TW200619211A (es) |
| UY (1) | UY29063A1 (es) |
| WO (1) | WO2006018115A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101272784A (zh) | 2005-09-29 | 2008-09-24 | 塞诺菲-安万特股份有限公司 | 苯基-和吡啶基-1,2,4-噁二唑酮衍生物、它们的制备方法和它们作为药物的用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2458210C (en) * | 2001-08-31 | 2011-09-20 | Aventis Pharma Deutschland Gmbh | Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar-activators |
| DE10308355A1 (de) * | 2003-02-27 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
-
2004
- 2004-08-14 DE DE102004039532A patent/DE102004039532B4/de not_active Expired - Fee Related
-
2005
- 2005-07-30 DE DE502005007249T patent/DE502005007249D1/de active Active
- 2005-07-30 AT AT05772240T patent/ATE430739T1/de not_active IP Right Cessation
- 2005-07-30 PT PT05772240T patent/PT1778655E/pt unknown
- 2005-07-30 BR BRPI0513999-6A patent/BRPI0513999A/pt not_active IP Right Cessation
- 2005-07-30 WO PCT/EP2005/008281 patent/WO2006018115A1/de active Application Filing
- 2005-07-30 KR KR1020077003581A patent/KR20070040813A/ko not_active Application Discontinuation
- 2005-07-30 DK DK05772240T patent/DK1778655T3/da active
- 2005-07-30 CN CNA2005800271498A patent/CN101031553A/zh active Pending
- 2005-07-30 MX MX2007000913A patent/MX2007000913A/es not_active Application Discontinuation
- 2005-07-30 EP EP05772240A patent/EP1778655B1/de not_active Not-in-force
- 2005-07-30 ES ES05772240T patent/ES2326423T3/es active Active
- 2005-07-30 JP JP2007525215A patent/JP2008509891A/ja not_active Abandoned
- 2005-07-30 AU AU2005274492A patent/AU2005274492A1/en not_active Abandoned
- 2005-07-30 CA CA002576545A patent/CA2576545A1/en not_active Abandoned
- 2005-08-09 SV SV2005002191A patent/SV2006002191A/es unknown
- 2005-08-10 PE PE2005000924A patent/PE20060624A1/es not_active Application Discontinuation
- 2005-08-11 AR ARP050103351A patent/AR050290A1/es not_active Application Discontinuation
- 2005-08-11 TW TW094127242A patent/TW200619211A/zh unknown
- 2005-08-12 UY UY29063A patent/UY29063A1/es unknown
-
2007
- 2007-01-28 IL IL181010A patent/IL181010A0/en unknown
- 2007-02-06 US US11/671,673 patent/US7956077B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AR050290A1 (es) | 2006-10-11 |
| CA2576545A1 (en) | 2006-02-23 |
| ATE430739T1 (de) | 2009-05-15 |
| DE502005007249D1 (de) | 2009-06-18 |
| TW200619211A (en) | 2006-06-16 |
| DE102004039532B4 (de) | 2006-09-21 |
| US20070197613A1 (en) | 2007-08-23 |
| DE102004039532A1 (de) | 2006-03-02 |
| EP1778655B1 (de) | 2009-05-06 |
| EP1778655A1 (de) | 2007-05-02 |
| SV2006002191A (es) | 2006-07-07 |
| ES2326423T3 (es) | 2009-10-09 |
| CN101031553A (zh) | 2007-09-05 |
| AU2005274492A1 (en) | 2006-02-23 |
| IL181010A0 (en) | 2007-07-04 |
| DK1778655T3 (da) | 2009-08-24 |
| KR20070040813A (ko) | 2007-04-17 |
| UY29063A1 (es) | 2006-02-24 |
| BRPI0513999A (pt) | 2008-05-20 |
| MX2007000913A (es) | 2007-04-16 |
| US7956077B2 (en) | 2011-06-07 |
| JP2008509891A (ja) | 2008-04-03 |
| WO2006018115A1 (de) | 2006-02-23 |
| PT1778655E (pt) | 2009-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20061348A1 (es) | DERIVADOS DEL ACIDO PIRMIDINCARBOXILICO COMO MODULADORES DE PPAR-alfa | |
| PE20060530A1 (es) | Aril y heteroaril derivados sustituidos como moduladores del metabolismo de la glucosa | |
| PE20060640A1 (es) | Derivados del acido alcanoico arilcicloalquil-sustituidos y procedimientos para su preparacion | |
| PE20020693A1 (es) | Agonistas del receptor alfa activado del proliferador de peroxisomas | |
| PE20081545A1 (es) | Derivados de sulfonamida como inhibidores de acido graso sintasas | |
| PE20060357A1 (es) | Compuestos y composiciones como moduladores de receptor activado de proliferador de peroxisoma (ppar) | |
| AR053415A1 (es) | Inhibidores dipeptidil peptidasa iv, composiciones farmaceuticas que los contienen y procesos para la preparacion de los compuestos y de la composicion | |
| AR061968A1 (es) | Ester isopropilico del acido 4-[5-metoxi-6-(2-metil-6-[1,2,4]triazol-i-il-piridin-3-il-amino)-pirimidin-4-iloxi]-piperidin-i-carboxilico, composicion farmaceutica que lo comprende y un metodo de preparacion de la misma y el uso de este compuesto para el tratamiento de trastornos metabolicos | |
| AR059895A1 (es) | Derivados biciclicos de acidos carboxilicos que resultan de utilidad para tratar trastornos metabolicos | |
| EA201001595A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
| PE20030414A1 (es) | Derivados de diarilcicloalquilo y procedimiento para su preparacion | |
| PE20041039A1 (es) | Derivados de pirazol como moduladores de ppar | |
| PE20090159A1 (es) | COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs | |
| AR048465A1 (es) | Derivados de acidos carboxilicos | |
| NO20051011L (no) | Kirale oksazol-arylpropionsyrederivater og anvendelse derav som PPAR agonister | |
| PE20141204A1 (es) | Compuestos novedosos como inhibidores de diacilglicerol aciltransferasa | |
| CO6351777A2 (es) | Compuestos de tetraciclina sustituidod con fluor en c7 | |
| RU2008127439A (ru) | Арилуксусная кислота и ее сложно-эфирные производные и их применение в качестве противовоспалительного средства | |
| PE20050292A1 (es) | Derivados de acido alcanoico sustituidos con aril-cicloalquilo, procedimientos para su obtencion y su empleo como medicamentos | |
| PE20081700A1 (es) | Derivados de acido de piranona sustituidos como agentes para tratar el sindrome metabolico | |
| AR077227A1 (es) | Compuesto de acido aril/ heteroaril- sustituido carboxilico, su uso para fabricar un medicamento util el tratamiento de afecciones o trastornos mediados por receptores s1p1, tales como esclerosis multiple y composicion farmaceutica que lo comprende | |
| AR093042A1 (es) | Derivados de etinilo | |
| PE20120217A1 (es) | Derivados de carbamatos de alquil-heterociclos, su preparacion y su aplicacion en terapeutica | |
| AR071721A1 (es) | Derivados de piridil-prolinamida, composiciones farmaceuticas que los contienen y su uso para el tratamiento de ansiedad, depresion y trastornos del sueno. | |
| PE20060624A1 (es) | Derivados de acido acetico con sustituyentes ciclohexilmetoxi como moduladores de los receptores ppar |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |